
Innovative Nasal Spray Shows Promise in Delaying Alzheimer's Progression
Researchers at Texas A&M University have developed a nasal spray that, in mouse models, reduces neuroinflammation and beta-amyloid plaques associated with Alzheimer's disease, potentially delaying its progression by up to 15 years. The spray targets microglia and astrocytes, cells involved in brain inflammation, and has shown promising results in improving cognitive and mood functions in treated mice. While the findings are encouraging, experts emphasize the need for further research and human trials to confirm the spray's efficacy and safety.




